Related references
Note: Only part of the references are listed.Next-Generation Anticancer Metallodrugs
Seiji Komeda et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
Protein tyrosine phosphatase Meg2 dephosphorylates signal transducer and activator of transcription 3 and suppresses tumor growth in breast cancer
Fuqin Su et al.
BREAST CANCER RESEARCH (2012)
STAT-3 Inhibitors: State of the Art and New Horizons for Cancer Treatment
A. Lavecchia et al.
CURRENT MEDICINAL CHEMISTRY (2011)
The gold compound auranofin induces apoptosis of human multiple myeloma cells through both down-regulation of STAT3 and inhibition of NF-κB activity
Aya Nakaya et al.
LEUKEMIA RESEARCH (2011)
Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase
Valentina Gandin et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Manumycin inhibits STAT3, telomerase activity, and growth of glioma cells by elevating intracellular reactive oxygen species generation
Deobrat Dixit et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Inhibition of Schistosoma mansoni Thioredoxin-glutathione Reductase by Auranofin STRUCTURAL AND KINETIC ASPECTS
Francesco Angelucci et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Thioredoxin reductase-1 knock down does not result in thioredoxin-1 oxidation
Walter H. Watson et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
STAT3: A critical transcription activator in angiogenesis
Zhong Chen et al.
MEDICINAL RESEARCH REVIEWS (2008)
Anti-cancer potential of gold complexes
E. R. T. Tiekink
INFLAMMOPHARMACOLOGY (2008)
Auranofin blocks interleukin-6 signalling by inhibiting phosphorylation of JAK1 and STAT3
Nam-Hoon Kim et al.
IMMUNOLOGY (2007)
Thioredoxin signaling as a target for cancer therapy
Garth Powis et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells
Christine Marzano et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Non platinum metal complexes as anti-cancer drugs
Ingo Ott et al.
ARCHIV DER PHARMAZIE (2007)
On the potential of thioredoxin reductase inhibitors for cancer therapy
Sabine Urig et al.
SEMINARS IN CANCER BIOLOGY (2006)
The role of p38 MAPK activation in auranofin-induced apoptosis of human promyelocytic leukaemia HL-60 cells
SJ Park et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Signal transducer and activator of transcription 3 (STAT3) regulates human telomerase reverse transcriptase (hTERT) expression in human cancer and primary cells
L Konnikova et al.
CANCER RESEARCH (2005)
Mitochondrial thioredoxin reductase inhibition by gold(I) compounds and concurrent stimulation of permeability transition and release of cytochrome c
MP Rigobello et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Auranofin induces apoptosis and when combined with retinoic acid enhances differentiation of acute promyelocytic leukaemia cells in vitro
IS Kim et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Gold compound auranofin inhibits IκB kinase (IKK) by modifying Cys-179 of IKKβ subunit
KI Jeon et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2003)
Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells
R Garcia et al.
ONCOGENE (2001)
Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors
T Hirano et al.
ONCOGENE (2000)
Thioredoxin reductase
D Mustacich et al.
BIOCHEMICAL JOURNAL (2000)
Share Paper
